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Abstract
A new analytical method using high performance liquid chromatography-diode array detector 
(HPLC-DAD) was developed for the analysis of 18 benzimidazoles and their metabolites in milk. Sam-
ples were extracted with acetonitrile and n-hexane and purified by polymer cation exchange (PCX) 
solid phase extraction cartridges. LC separation was performed on Xbridge C18 with gradient elution 
using acetonitrile and ammonium acetate buffer. The DAD detection was set at 298, 312, 254 and 
290 nm. The method was validated according to the criteria of Commission Decision 2002/657/EC. 
The following validation parameters were set: accuracy (expressed as recovery) 31.7-137.6 %, limit 
of decision (CCα) 6.0-120.6 µg kg-1, detection capability (CCβ) 6.1-120.8 µg kg-1, limit of detection 
(LOD) 1-4 µg kg-1, limit of quantification (LOQ) 4-18 µg kg-1, precision as CV 7.0-22.5 %, within-
laboratory reproducibility expressed as CV 8.8-30.6 %. Finally, the developed method was applied 
to the analysis of collected milk samples. A total of 50 milk samples was analysed for benzimidazole 
residues. All obtained concentrations for all compounds were below the LOQ values.
Key words: benzimidazoles, milk, HPLC-DAD, validation
Introduction
Benzimidazoles are veterinary drugs widely 
used for the prevention and treatment of parasitic 
infections in agriculture and aquaculture, includ-
ing food producing animals (Danaher, 2007). The 
extensive use of benzimidazoles in lactating animals 
could result in the presence of their residues in milk 
and dairy products, which is harmful to consumers 
owing to their teratogenic and embryotoxic prop-
erties (Chen et al., 2010.). To ensure human food 
safety, the European Union set a maximum residue 
limits (MRLs) in animal tissues for most benzimida-
zoles, though only albendazole, fenbendazole, tric-
labendazole and thiabendazole have MRL values in 
milk (EC, 2010; EC, 2012; EC, 2014). The marker 
residue of almost all the benzimidazoles is defined 
as the sum of a parent drug and/or its metabolites.
The extraction and purification of benzimida-
zole residues from milk poses a difficult challenge. At 
present, the majority of methods used for detection 
of benzimidazole residues from milk do not general-
ly include the complete range of marker residues for 
each substance. For effective control, benzimidazole 
residues in foods, including milk, methods capable 
of detecting the complete range of marker residues 
should be applied. In recent years, liquid chroma-
tography coupled with tandem mass spectrometry 
(LC-MS/MS) has found more widespread applica-
tion in benzimidazole residue analysis, offering more 
sensitive detection and increased confidence in re-
porting results (De Ruyck et al., 2002; Jedziniak 
et al., 2009; Xia et al., 2010; Chen et al., 2011). 
However, mass instruments are still quite expensive 
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and not readily available to chemists in most labo-
ratories. HPLC is the most widely applied method 
to separate residues of benzimidazoles drugs. Al-
though fluorescence is more sensitive and selective, 
the most widely applied detector is ultraviolet (UV) 
(Takeba et al., 2000; De Ruyck et al., 2000).
The development of methods that cover the 
complete number of marker residues or the most 
persistent or predominant metabolites is difficult. As 
a result, a number of important benzimidazole resi-
dues, such as triclabendazole (TCB) and its metabo-
lites, are not included into multi-residue methods. 
To date, there is only one published multi-residue 
method that encompasses 11 benzimidazoles and 10 
metabolites in milk using the HPLC-UV technique 
(Chen et al., 2010). Disadvantages of that method 
are the long analysis time for HPLC-UV, which takes 
80 min, and the fact that it does not include one of 
the triclabendazole metabolites - ketotriclabenda-
zole. The aim of this study was to develop a HPLC 
multi-residue method with DAD detection for the 
determination of benzimidazole markers and their 
metabolites in milk. The developed method was ap-
plied to the analysis of real milk samples taken from 
dairy farms in Croatia.
Experimental
Drugs and reagents
Analytical standards of albendazole sulphox-
ide (ABZ-SO), albendazole sulphone (ABZ-SO
2), 
albendazole-2-amino-sulphone (ABZ-NH2-SO2), 
hydroxy mebendazole (MBZ-OH), amino meben-
dazole (MBZ-NH2), triclabendazole sulphoxide 
(TCB-SO), triclabendazole sulphone (TCB-SO2), 
and ketotriclabendazole (KTCB) were purchased 
from Witega (Berlin, Germany). Mebendazole 
(MBZ), fenbendazole (FEBZ), fenbendazole sulph-
oxide (oxfendazole, OFZ), fenbendazole sulphone 
(FEBZ-SO2), thiabendazole (TBZ), 5-hydroxy 
thiabendazole (5-OH-TBZ), flubendazole (FLU), 
2-aminoflubendazole (FLU-HMET), oxibendazole 
(OXI) and nocodazole (NOC) as the internal stand-
ard were purchased from Sigma Aldrich (St. Louis, 
MO, USA).
Chemicals of analytical grade including glacial 
acetic acid, ammonium acetate, ammonium hydrox-
ide, hydrochloric acid, anhydrous sodium sulphate, 
dimethylsulfoxide (DMSO), n-hexane and ethanol 
were supplied from Kemika (Zagreb, Croatia). Ace-
tonitrile and methanol were HPLC-grade and also 
obtained from Kemika (Zagreb, Croatia). Water 
was purified with a Millipore DirectQ5 UV system 
(Merck Millipore, USA).
The ammonium hydroxide-acetonitrile solution 
used for the eluation of analytes was prepared on 
the day of use by mixing 160 mL acetonitrile with 
22 mL conc. ammonium hydroxide and making up 
to 200 mL with acetonitrile.
The cartridge used for solid phase extraction 
(SPE) was PLEXA PCX cartridge (500 mg, 6 mL, 
Agilent, Milford, HA, USA).
Prior to HPLC injection, samples were filtered 
through a 0.45 µm PTFE syringe filter from Filter-
Bio (Nantong City, Jiangsu P.R China).
Preparation of stock and working solutions
Individual stock standard solutions (1 mg/mL) 
of all analytes were made by dissolving each stand-
ard in DMSO and stored at -20 °C for 5 years.
For linearity testing, a mixed standard solution 
containing 20 or 50 µg mL-1 of all compounds was 
prepared by combining 200 or 500 µL of each stand-
ard stock solution and diluting to 10 mL with etha-
nol. For other validation parameters study, a mixed 
standard solution containing 2.5 or 5 µg mL-1 was 
prepared. The solutions were stored at -20 °C for 
1 year. During these periods we have not observed 
any signs of decomposition of analytes. Standard 
working solutions, at various concentrations, were 
prepared daily by the appropriate dilution of the 
mixed standard solution with mobile phase A. 
Sample collection
Cow milk samples were collected by authorized 
veterinarians at dairy farms in different regions of 
continental Croatia. In total, 50 milk samples were 
sampled in different counties: 7 in Zagreb County, 
8 in Krapina Zagorje County, 8 in Karlovac County, 
8 in Koprivnica Krizevci County, 6 in Brod Posavina 
County, 13 in Baranya County. Milk samples were 
collected in a polyethylene bottle of 50 mL volume. 
Samples were stored at -20 °C until the time of 
analysis. Analysed milk samples that were found to 
contain no detectable residues of the analytes were 
used as the negative controls (blank).
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Sample preparation
A 10 g sample of milk was weighed into a 
50 mL centrifuge tube and 2-3 g anhydrous sodium 
sulphate was added. The mixture was vortexed for 
1 min and 10 mL acetonitrile was added. This mix-
ture was shaken for 10 min and centrifuged for 
15 min at 3600 rpm. The supernatant was decant-
ed into another 50 mL centrifuge tube containing 
10 mL water and 10 mL 0.1 M hydrochloric acid. 
This mixture was washed with 10 mL hexane 
(shaken for 10 min, centrifuged for 5 min at 
3000 rpm), the hexane phase was discarded and the 
rest was diluted with water to 50 mL.
The PCX cartridge was pre-conditioned with 
5 mL methanol and 5 mL water. Entire extracts 
were loaded onto the SPE. The column was washed 
twice with 5 mL 0.1 M hydrochloric acid and then 
with 5 mL methanol. The column was then dried 
by purging air at 600 mbar for 10 min. The analytes 
were eluted with 10 mL ammonium hydroxide-
acetonitrile solution, evaporated to dryness under 
nitrogen at 40 °C and redissolved in 40 µL metha-
nol, vortexed for 1 min, with the addition of 160 µL 
mobile phase A, vortexed for 1 min and the solution 
was filtered before HPLC analysis.
Instrumentation and chromatographic conditions
Benzimdazole determination was performed 
using HPLC-DAD system comprising of 1260 de-
gasser, 1260 dual pump system, 1290 autosampler, 
1260 column oven and 1200 DAD detector (Agilent, 
Palo Alto, CA, USA). Gradient elution using col-
umn Xbridge C18 4.6 x 150 mm, 3.5 µm equipped 
with a guard column 3.5 µm, 4.6x20 mm was used 
for chromatographic separation (Waters Corp., 
Milford, MA, USA). The column temperature was 
maintained at 55 °C in gradient mode with buffer 
solution containing 0.01 M ammonium acetate to 
pH 5.7 with 1 % acetic acid as mobile phase A and 
acetonitrile as mobile phase B. The gradient program 
was: 0 min 82 % A, 20 min 67 % A, 25 min 10 % A, 
26 min 82 % A. The flow rate during analysis was 
1 mL/min. The injected volume was 50 µL and the 
DAD analysis was performed monitoring four dif-
ferent wavelengths: 298, 312, 254 and 290 nm with 
scan the entire spectrum from 190 to 320 nm.
Method validation
The developed method was validated according 
to procedures described in Commission Decision 
2002/657/EC covering specificity, calibration curve 






In order to determine validation parameters, 
different amounts (100, 200 or 300 µL) of working 
standard solution (0.5 respectively 5 µg mL-1) were 
added to 10 g samples of bovine and ovine milk free 
from benzimidazoles. The samples were held at 
room temperature for 15 min prior to extraction 
ensuring absorption of the standard solution. The 
results of validation were calculated for individual 
substances.
Selectivity. To establish the selectivity/specific-
ity of the method, milk samples fortified with the 
benzimidazoles at MRLs and at 5 µg kg-1 for sub-
stances without MRLs and non-fortified samples 
were analysed to verify the absence of interfering 
substances around the retention time of analytes
Linearity and quantitative analysis. Standard 
calibration curves were prepared with the injection 
of working standard solutions at six concentration 
levels from 0.125 to 4 µg mL-1 respectively from 
0.3125 to 10 µg mL-1 and calculated using linear 
least squares regression analyses of the peak area to 
concentration ratios.
Precision and accuracy. To estimate the preci-
sion of the analytical method, blank milk samples 
were fortified with a standard working solution 
(0.5 respectively 5 µg mL-1) containing a mix of 
benzimidazoles at least three levels for substances 
with MRLs (5, 10 and 15 µg kg-1; 25, 50, 100 and 
150 µg kg-1) and at three levels for substances with-
out MRLs (5, 10 and 15 µg kg-1) in six replicates 
for each concentration. The complete extraction 
and purification procedures were performed for the 
spiked samples. Within-laboratory reproducibility 
was determined by repeating the study on three 
consecutive days with two different analysts and dif-
ferent lots of chemicals. For each level, the average 
concentration, standard deviation (SD), coefficient 
of variation (CV, %) and recovery were calculated.










) were calculated using within-
laboratory reproducibility validation results, accord-
ing to the equation:
- for substances with MRLs
CC
α





 + 1.64 × SDWLR
MRL- concentration equal to MRL value; 
SDWLR - standard deviation of within-laboratory re-
producibility,
- for substances without MRLs
CC
α





 + 1.64 × SDWLR,C0
c0- concentration equal to the lowest spiking 
level; SDWLR,C0 - standard deviation of within-labora-
tory reproducibility at c0
LOD and LOQ. Limit of detection (LOD) was 
calculated on the basis of the lowest concentration 
according to the equation:
LOD = SDWLR,C0 × t0,02
LOQ = 10 × SDWLR,C0
t0,02 - student t value at n-1 degrees of freedom 
and probability of 98%; SDWLR,C0 - standard devia-
tion of within-laboratory reproducibility at c0.
Statistical analysis of data
Statistical analysis of the results data of valida-
tion parameters was performed using the Microsoft 
Excel program. Calculated statistical values included 
the mean, standard deviation (SD) and coefficient 
of variation (CV %). Results data were analysed with 
statistical method Anova Single Factor with level of 
significance p=0.05.
Results and discussion
In this study, we were looking for a simple, 
fast and reliable method for the determination of 
benzimidazole drugs. Due to the great difference 
in chemical properties, it was difficult to develop a 
method to cover the entire range of benzimidazoles. 
Acetonitrile and ammonium acetate buffer were se-
lected as the mobile phase according to Chen et al. 
(2010). The maximum sensitivity and satisfactory 
separation of all analytes was achieved when using 
0.01 M ammonium acetate (pH 5.7 with 1 % ace-
tic acid). The gradient was optimized to provide the 
maximum separation possible in minimum time pe-
riod. The biggest challenge was to separate all tricla-
bendazole metabolites, since they elute very closely. 
Column temperature, in addition to the concentra-
tion of acetonitrile in the mobile phase, proved to be 
an important separation factor.
No interfering peaks were observed for the reten-
tion time for benzimidazoles, except for the retention 
times for the triclabendazole metabolites and FEBZ-
SO
2 (Fig. 1) where an interfering peak of negligible 
size, relative to MRL concentration, were observed.
The linearity of standard calibration curves was 
acceptable and within the range from 0.125 to 4 µg 
mL-1 respectively from 0.3125 to 10 µg mL-1 and val-
ues of R2 for all anaytes were above 0.99.
Figure 1. LC-UV chromatograms at 297 nm of blank milk (gray) and spiked with benzimidazoles at MRLs 
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Mean recoveries (n = 6) of the analytes, de-
termined in six separate assays, were between 60 % 
and 100 % (Table 1). Lower mean recoveries of 
approximately 30 % were obtained for KTCB and 
TCB-SO2, higher mean recoveries of approximate-
ly 120 % were obtained for ABZ-SO2 and 135 % 
FEBZ-SO2. These obtained values were not acceptable 
according to Commission Decision 2002/657/EC, 
but since the statistical analysis ANOVA showed no 
differences among the results, and because of com-
parability with the results of other studies, obtained 
results were accepted in that kind with obligatory 
correction when expression results. The procedure 
did not prevent the oxidation of benzimidazoles. 
This is especially notable in the case of high recov-
eries of FEBZ-SO2. Similar low values for recover-
ies (21-33 %) and low precision of determination 
(CV 22-34 %) of FEBZ together with high recover-
ies of FEBZ-SO and FEBZ-SO2 were found in study 
of Jedziniak et al. (2009). The authors described 
sample preparation as extracting analytes from an 
alkalized matrix to ethyl acetate and then defatting 
the extract with hexane. To prevent the oxidation of 
benzimidazoles, two antioxidant agents were used. 
TCB metabolites were recovered at approximately 
30-50 %. Although authors used different methods 
of sample preparation comparing to our method, 
obtained similar validation results indicate further 
need to develop methods of sample preparation with 
the aim of better results for validation parameters 
of named analytes. Another possibility is expressing 
validation results for the sum of parent compounds 
and their metabolites which showed more reliable 
accuracy and precision than for individual substances 
(Jedziniak et al., 2009.). Danaher et al. (2007) 
indicated that TCBZ metabolites are in a neutral state 
at a lower pH than other benzimidazoles and that this 
can have an influence on the repeatability of the ex-
traction of these compounds. In a similar study us-
ing liquid-liquid extraction, sample preparation with 
acetonitrile, with an additional solid-phase sample 
extraction step procedure, followed by quantification
Table 1. The validation results for parameter recovery, precision and within-laboratory reproducibility for 
benzimidazoles in milk







5-OH-TBZ 68.0±5.3 11.7±3.1 9.5±1.8
ABZ-NH2-SO2 69.7±3.1 7.6±5.7 9.4±2.0
ABZ-SO 71.7±2.4 7.0±5.6 9.0±2.1
TBZ 76.5±7.4 12.3±4.2 10.4±3.7
ABZ-SO2 121.2±4.5 7.0±5.4 8.8±2.3
OFZ 97.0±8.5 9.2±7.2 13.1±2.5
MBZ-NH2 62.8±4.9 8.1±5.6 13.6±0.3
MBZ-OH 73.2±7.3 20.8±6.7 20.8±4.6
FLU-HMET 101.4±31.0 9.3±5.9 16.8±2.6
FEBZ-SO2 137.6±10.4 7.5±5.5 10.9±0.6
OXI 77.7±3.4 7.2±5.1 10.7±0.5
MBZ 85.4±8.1 6.6±4.9 10.5±1.4
FLU 83.0±1.5 8.0±5.8 14.3±1.5
FEBZ 67.6±11.3 12.0±3.1 19.1±7.4
TCB-SO2 25.4±19.4 17.0±6.0 37.0±1.9
KTCB 31.7±7.3 22.5±5.2 29.4±9.4
TCB-SO 53.6±10.6 11.2±2.8 30.6±13.8
TCB 69.5±19.9 16.5±8.2 24.2±9.5
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, LOD and LOQ
by HPLC-UV method, the recoveries were deter-
mined in the range from 78 % to 109 % (Chen et 
al., 2010). The reported method did not include the 
metabolite KTCB. To quantify the target analytes in 
milk, the authors used matrix-matched calibration 
curves within the range from 10 to 200 µg kg-1. The 
validated method described in this study covers the 
range from 2.5 to 200 µg kg-1, which is a much lower 
concentration range. In another study on the de-
termination of anthelmintic compounds, including 
benzimidazole compounds, using the QuEChERS 
procedure for sample preparation and detection by 
UPLC-MS/MS, a recovery of 70-110 % was ob-
tained (Whelan et al., 2010). 
The results of accuracy and precision data are 
summarized in Table 1. For most analytes, CV% val-
ues were less than 26 %. In some instances (TCB 
metabolites), CV% values were in excess of 25 %. 
CV theoretical was calculated according to the 
Horowitz equation CV% = 2 1-0,5logC and compared 
to the validation results data. In the case of not 
matching results data were analysed with the statis-
tical method Anova Single Factor (p=0.05), which 
found no significant differences among the results. 
Chen et al. (2010) showed intermediate precision 
expressed as RSD % in the range 4-16 %. Compar-
ing all analyses, higher values were obtained for TCB 
and its metabolites. The data reported in that study 
were obtained in the analysis of the corresponding 
samples at 10, 50 and 100 µg kg-1, which was only 
partially comparable to the present study since vali-
dation results for substances without MRLs were ob-
tained at lower concentrations: 5, 10 and 15 µg kg-1. 
In another study using the QuEChERS procedure 
for sample preparation, CV% for repeatability was 
>23 % for TCB-SO, TCB-SO2 and 5-OH-TBZ at 
low level validation (2, 3 and 4 µg kg-1) (Whelan et 
al., 2010). 
In the present study, low values were obtained 
for LOD (1-4 µg kg-1) and LOQ (4-18 µg kg-1). Sen-
sitivity of the method was far below the MRL lev-
els. Chen et al. (2010) obtained a similar LOD and 
LOQ values of 3 and 10 µg kg-1 using HPLC-UV. 
However, in another study using ultra high perfor-
mance liquid chromatography and tandem mass 
spectrometry (UHPLC-MS/MS), LOD values were 
much lower: 0.1-0.6 µg L-1 (De Ruyck et al., 2002) 
and <1 µg kg-1 (Whelan et al., 2010).
Compound CC
α
 (µg kg-1) CC
β
 (µg kg-1) LOD (µg kg-1) LOQ (µg kg-1)
5-OH-TBZ 111.7 111.9 3.2 13.3
ABZ-NH2-SO2 112.2 112.3 3.0 12.5
ABZ-SO 112.2 112.4 2.7 11.2
TBZ 116.3 116.6 2.6 10.8
ABZ-SO2 120.6 120.8 4.3 17.7
OFZ 12.3 14.6 1.8 7.6
MBZ-NH2 6.0 6.1 1.1 4.5
MBZ-OH 6.7 6.8 1.8 7.5
FLU-HMET 7.5 7.5 2.6 10.7
FEBZ-SO2 12.6 15.1 2.0 8.3
OXI 6.0 6.0 1.1 4.4
MBZ 6.2 6.2 1.3 5.2
FLU 6.5 6.6 1.6 6.7
FEBZ 12.3 14.5 1.1 4.4
TCB-SO2 12.4 12.5 1.1 4.5
KTCB 12.8 12.9 1.5 6.0
TCB-SO 14.8 14.9 1.2 4.7
TCB 14.1 14.2 1.5 6.2





 values are summarised in 
Table 2. Obviously, the highest percentile deviation 
on the target concentration was obtained for analytes 
without an MRL and analytes with a lower value of 










ues determined using UHPLC-MS/MS analysis were 
lower than those reported here, and ranged from 0.14 
to 1.9 and 11 to 123 µg kg-1 for unapproved and MRL 
substances, respectively (Whelan et al., 2010). 
Application of the method
The described analytical method was applied to 
real samples to assess the occurrence of anthelmintic 
drugs. In the present study, 50 samples of raw milk 
were collected in Croatia during 2014 and analysed. 
No detectable residues of the target analytes were 
found in any of these samples. 
Conclusions
This paper reports the development and valida-
tion for a HPLC–DAD method for the simultane-
ous determination of following benzimidazoles and 
their metabolites: albendazole sulphoxide, alben-
dazole sulphone, albendazole-2-amino-sulphone, 
hydroxy mebendazol, amino mebendazole, tricla-
bendazole sulphoxide, triclabendazole sulphone, 
ketotriclabendazole, mebendazole, fenbendazole, 
fenbendazole sulphoxide, fenbendazole sulphone, 
thiabendazole, 5-hydroxy thiabendazole, flubenda-
zole, 2-aminoflubendazole and oxibendazole. Benz-
imidazoles compounds were successfully separated 
by HPLC. The method has satisfactory validation 
characteristics according to Commission Deci-
sion 2002/657/EC for almost all analytes, except 
for KTCB, TCB-SO2, FEBZ-SO2 and ABZ-SO2. 
Statistical analysis of the validation results have not 
observed any significant differences within results, 
so with obligatory correction of recovery when ex-
pressing results, method is suitable for the routine 
determination of benzimidazoles residues in milk. 
Further development of method in step of sample 
preparation in order to get a satisfactory validation 
parameters of listed analytes should be taken or vali-
dation for the sum of parent compounds and their 
metabolites should be carried out.
 Određivanje ostataka benzimidazola i 
njihovih metabolita u sirovom mlijeku  
u Hrvatskoj primjenom tekućinske  
kromatografije visoke djelotvornosti  
uz detektor s nizom dioda
Sažetak 
Razvijena je nova analitička metoda za 
određivanje 18 benzimidazola i njihovih metabo-
lita u mlijeku primjenom tekućinske kromatografi-
je visoke djelotvornosti uz detektor s nizom dioda 
(HPLC-DAD). Uzorci su ekstrahirani acetonitrilom 
i n-heksanom, te pročišćeni primjenom patrona 
punjenih polimernim kationskim izmjenjivačem 
(PCX). Kromatografska analiza provedena je na 
koloni Xbridge C18 uz gradijentu eluaciju acetonitri-
lom i amonijevo-acetatnim puferom. DAD detekcija 
praćena je na 298, 312, 254 i 290 nm. Metoda je va-
lidirana u skladu s Odlukom Komisije 2002/657/EZ. 
Utvrđeni su sljedeći parametri validacije: točnost 
(izražena kao iskorištenje) 31,7-137,6 %, granična 
koncentracija određivanja (CCα) 6,0-120,6 µg kg-1, 
sposobnost dokazivanja (CCβ) 6,1-120,8 µg kg-1, 
granica određivanja (LOD) 1-4 µg kg-1, granica kvan-
tifikacije (LOQ) 4-18 µg kg-1, preciznost izražena 
kao CV 7,0-22,5 %, unutar-laboratorijska repro-
ducibilnost izražena kao CV 8,8-30,6 %. Konačno, 
razvijena metoda primijenjena je za analizu priku-
pljenih uzoraka mlijeka. Ukupno 50 uzoraka mlijeka 
analizirano je na ostatke benzimidazolnih lijekova i 
njihovih metabolita. Sve koncentracije za sve ana-
lizirane spojeve ispod su LOQ vrijednosti. 
Ključne riječi: benzimidazoli, mlijeko,  
HPLC-DAD, validacija
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